UCLA Center for IBD

12/06/2016

How many of these points hit home to you?
BuzzFeed & CCFA - Crohn's & Colitis Foundation of America article about invisible diseases.

Tired of hearing "But you don't look sick...?" Participate in Crohn's and Colitis Awareness Week and be .

11/02/2016

New from UCLA research, about familial and how microbes can predict risk.

Healthy family relatives can have a microbial imbalance that can represent predisease or susceptibility to inflammation.

http://www.cmghjournal.org/article/S2352-345X(16)30074-1/fulltext?elsca1=etoc&elsca2=email&elsca3=2352-345X_201611_2_6_&elsca4=Gastroenterology%7CHepatology%7CBasic%20Medical%20Science …

Microbes may increase susceptibility to inflammatory bowel disease (IBD) by producing bioactive metabolites that affect immune activity and epithelial function. We undertook a family based study to identify microbial and metabolic features of IBD that may represent a predisease risk state when found...

10/19/2016

Do you know there are cases of Stem Cell therapy used to treat ?

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4913333/

Inflammatory bowel disease (IBD) is a chronic, often relapsing, condition that deeply impacts the quality of life for many patients. Although there have been significant advances in medical treatments, a large proportion of patients become refractory ...

09/28/2016

Stelara for IBD is now approved by the FDA

This week the US Food and Drug Administration (FDA) approves use of ustekinumab (Stelara, Janssen) for the use in treatment of Crohn's disease patients who are moderate to severely active.

Stelara is used for patients who have previously failed or non-responsive to immunomodulator or corticosteroid therapy, but have not failed treatment with a tumor necrosis factor (TNF) blocker. For the mechanism of action, Stelara is is the first biologic therapy that targets Interleukin-12/23 cytokines, and aims to disrupt those signaling cascades which lead to inflammatory and immune responses.

Please discuss treatment options with your GI physician for further questions.

09/27/2016

New research showing specific fungal interactions with the gut microbiome and Crohn's Disease in IBD.

A fungus has been identified as a key factor in the development of Crohn's disease, an international team of researchers has identified for the first time.

08/19/2016

Integrating (cognitive behavioral therapy) for insomnia.
This form of psychotherapy has been catching popularity this past week. CBT focuses on making yourself conscious about negative thoughts due to challenging life situations, and then allowing yourself to analyze the anxious emotions and to respond in a more positive, progressive and effective way.

Our center's team has been deep in development the past year to integrate CBT therapy for our patients.

We are in the final steps of finalizing this unique option within our "UCLAeIBD" app available in all apple and android app stores. Keep an eye out for the first release!

Cognitive behavioral therapy for insomnia, or C.B.T.-I., asks you to replace the negative thought that’s keeping you awake with a positive one.

08/10/2016

CCFA - Crohn's & Colitis Foundation of America Los Angeles Patient and Family Education Conference coming up on October 9th 2016
9:30am - 3:30pm
Where: Cedars-Sinai Medical Center, Harvey Morse Conference Center (8700 Beverly Blvd., Los Angeles, CA 90048)

Mark your calendars! The Crohn's & Colitis Foundation of America, Greater Los Angeles Chapter is proud to offer patients, families, and caregivers a full day of lectures presented by leading experts in the field of inflammatory bowel disease (IBD). This conference is designed to educate the IBD patient community about new developments in treatment, surgical techniques, use of complementary and alternative therapies, research, nutrition, and psychosocial issues. Register now for this year's patient education conference!

For the agenda breakdown and registration for the event, please visit: http://www.ccfa.org/chapters/losangeles/events/los-angeles-patient-and.html

A full-day conference designed to educate the IBD patient community about new developments.

08/09/2016

Don't let any disease define you!
Surely Olympian Kathleen Baker didn't let Crohn's say what she could or couldn't do.

Baker, 19, who has been dealing with the disease since she was about 13, will compete for the United States in the 100-meter backstroke in Rio de Janeiro.

08/08/2016

Location for our clinic will be moving locations to the newly renovated Suite 345 in the building:
100 Medical Plaza
Los Angeles 90024

Thank you!

07/28/2016

Videos from the 4th Annual UCLA-Mellinkoff GI and Hepatology Symposium has been posted online here at: http://gastro.ucla.edu/body.cfm?id=468

Be sure to check out our center's IBD specialist physicians Dr. Daniel Hommes & Dr. Christina Ha discuss on the panel about Case-based Discussion on Complicated Crohn's Disease

Christina Ha, MD
Daniel Hommes, MD, PhD

Event date: March 11-13, 2016

Our faculty have been leaders in health-related events through out the region. We regularly conduct education programs for health care professionals including continuing medical education (CME) sessions for physicians and contact hour (CE) sessions for nurses. We hope that you will join us for these...

06/30/2016

A study presented at this year's Digestive Disease Week® (DDW®) shows that a multi-week yoga program may help decrease disease activity and increase quality of life for patients with .

Great for those who are enrolled in our program which gives all patients access to the wellness suite in the "UCLAeIBD" application available in all iPhone and android smartphones!

Our 6-week program is great for beginners and aims to reduce stress through mindfulness therapy and light and easy to follow yoga poses!

*Important to note wellness therapies are used as a complementary form of therapy in treatment of care.

SAN DIEGO — A 12-week hatha yoga intervention reduced disease activity and improved quality of life and mental health in patients with ulcerative colitis, according to randomized controlled trial results presented at DDW. Twenty percent to 61% of ulcerative colitis patients “report the u...

06/28/2016

An Intimate Photography Book To Raise Awareness For Sufferers Of Inflammatory Bowel Diseases

Women share their courage in their battle against invisible disabilities.Padua, Italy - June 01, 2016 - Chiara De Marchi, a photographer, has launched the